Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Preliminary results
|
|
T2 Biosystems, Inc. (TTOO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/14/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 04/05/2023 |
4/A
| Gibbs Michael Terrence (General Counsel) has filed a Form 4 on T2 Biosystems, Inc.|
Txns:
| Exercised 334 restricted stock units
@ $0 |
|
| 03/29/2022 |
4/A
| Sprague John M (CFO) has filed a Form 4 on T2 Biosystems, Inc.|
Txns:
| Paid exercise price by delivering 55,008 shares
@ $0.4488, valued at
$24.7k
Exercised 145,719 restricted stock units
@ $0 |
|
| 03/29/2022 |
4/A
| Sprague John M (CFO) has filed a Form 4 on T2 Biosystems, Inc.|
Txns:
| Paid exercise price by delivering 3,775 shares
@ $0.466, valued at
$1.8k
Granted 600,000 restricted stock units
@ $0
Exercised 10,000 restricted stock units
@ $0 |
|
| 03/28/2022 |
4/A
| Gibbs Michael Terrence (General Counsel) has filed a Form 4 on T2 Biosystems, Inc.|
Txns:
| Paid exercise price by delivering 76,867 shares
@ $0.4488, valued at
$34.5k
Exercised 145,719 restricted stock units
@ $0 |
|
| 03/28/2022 |
4/A
| Gibbs Michael Terrence (General Counsel) has filed a Form 4 on T2 Biosystems, Inc.|
Txns:
| Paid exercise price by delivering 5,275 shares
@ $0.466, valued at
$2.5k
Granted 600,000 restricted stock units
@ $0
Exercised 10,000 restricted stock units
@ $0 |
|
| 03/19/2021 |
4/A
| Sperzel John J III (President and CEO) has filed a Form 4 on T2 Biosystems, Inc.|
Txns:
| Granted 1,000,000 restricted stock units
@ $0 |
|
|
|